To investigate whether MG53 had any effect on the RAC1 activity, RAC1 GTPase activity assay was performed and our data showed that MG53 significantly inhibited RAC1 activity in HCC cells (Fig. 2C). This evidence concerns the gene RAC1 and hepatocellular carcinoma.